NEURO2022

Session information

Late-Breaking Abstracts

[2LBA] Late-Breaking Abstracts

Fri. Jul 1, 2022 11:00 AM - 12:00 PM Poster Session Hall 2 (Ginowan City Gymnasium)

*Kyoka Suyama1, Satoshi Miyashita2, Keiya Iijima3, Koichi Hashizume1, Nao Tabe1, Masaki Iwasaki3, Shinichiro Taya1, Mikio Hoshino1 (1. Department of Biochemistry and Cellular biology, National Institute of Neuroscience, NCNP, 2. Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, 3. Department of Neurosurgery, National Center Hospital, NCNP)

*Eri Kawashita1,2, Jan Fischer1, Yumi Fukuzaki1,3, Lancelot Millar1, Peiyun Zhong4, Anna Hoerder-Suabedissen1, Lei Shi4, Zoltán Molnár1 (1. Dept of Physiology, Anatomy and Genetics, Univ of Oxford, Oxford, UK, 2. Dept of Pathological Biochemistry, Kyoto Pharmaceutical University, Kyoto, Japan, 3. Dept of Neurology, UCSF, CA, 4. JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangdong, China)

*Koyo Tsujikawa1, Kohei Hamanaka2, Yuichi Riku1,3, Yuki Hattori4, Yohei Iguchi1, Kenta Kobayashi5, Takeshi Ikeuchi6, Takaki Miyata4, Naomichi Matsumoto2, Kentaro Sahashi1, Masahisa Katsuno1 (1. Department of Neurology, Nagoya University Graduate School of Medicine, 2. Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3. Department of Neuropathology, Institute for Medical Science of Aging,, 4. Department of Anatomy and Cell Biology, Nagoya University Graduate School of Medicine, 5. Section of Viral Vector Development, National Institute for Physiological Sciences, 6. Department of Molecular Genetics, Brain Research Institute, Niigata University)

*Hironori Takamura1,2, Yoshiaki Nakayama3, Hidefumi Ito3, Taiichi Katayama1, Paul E Fraser2,4, Shinsuke Matsuzaki1,5 (1. United Graduate School of Child Development, Osaka University, Osaka, Japan, 2. Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada, 3. Department of Neurology, Wakayama Medical University, Wakayama, Japan, 4. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada, 5. Department of Radiological Sciences, Faculty of Health Sciences, Morinomiya University of Medical Sciences, Osaka, Japan)

*Ming-Chia Chu1, Chi-Wei Lee1, Ching-Hsiang Chang1, Chieh-Yu Chang1, Tzu-Ning Peng1, Tzu-Jung Yang1, Yen-Cheng Lin1, Hsiang Chi1, Guang-Huar Young2, Hui-Ching Lin1,3 (1. Department and institute of Physiology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221 Taiwan, 2. Energenesis Biomedical Co. Ltd, Taipei, 11492 Taiwan, 3. Brain Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan)

*Yuka MORIYA1, Akihiro MOURI2,5, Mai MIYACHI1, Hitomi KURAHASHI2, Takemi Fuwa2, Takaya NISHIKAWA2, Toshitaka NABESHIMA3,5, Kuniaki SAITO4,5, Yoichi HASEGAWA1 (1. Faculty of Pharmacy, Meijo University, Japan, 2. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Japan, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Japan, 4. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Japan, 5. Japanese Drug Organization of Appropriate Use and Research, Japan)

*Kyoka Tsukuda1, Takashi Kubota2, Aoi Chiba4, Takashi Tominaga1, Yasushi Kishimoto3, Kentaro Nakashima1 (1. Institute of Neuroscience, Tokushima Bunri University, Kagawa, Japan, 2. Laboratory of Pharmacol., Kagawa Sch. Phrmaceut. Sci., Tokushima Bunri Univ., Kagawa, Japan, 3. Laboratory of Physical Chemistry, Faculty of Pharma Sciences, Teikyo University, Tokyo, Japan, 4. Department of Neurobiophysics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Kagawa, Japan)

*Chieh-Yu Chang1, Chi-Wei Lee1, Ming-Chia Chu1, Tzu-Jung Yang1, Ching-Hsiang Chang1, Tzu-Ning Peng1, Yen-Cheng Lin1, Hsiang Chi1, Hsun-Shuo Chang3, Hui-Ching Lin1,2 (1. Department and Institute of Physiology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 2. Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, 3. School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan)

*Yuuki Uchida1,2, Shingo Murata3, Takafumi Soda1,2, Kentaro Katahira4, Shinsuke Suzuki5, Yuichi Yamashita1 (1. Department of Information Medicine, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan, 2. Grad Sch Med and Dent, Tokyo Medical and Dental Univ, Tokyo, Japan, 3. Department of Electronics and Electrical Engineering, Keio Univ, Tokyo, Japan, 4. Mental and Physical Functions Modeling Group, Human Informatics and Interaction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan, 5. Brain, Mind and Markets Laboratory, Department of Finance, Faculty of Business and Economics, The University of Melbourne, Melbourne, Victoria, Australia)

*Yuji Nakamura1, Issei S Shimada1, Masanori Fujimoto1, Emi Sato1, Akihiko Miyauchi2, Fuyuki Miya3, Tatsuhiko Tsunoda4, Yukimune Okubo5, Kazuhiro Haginoya5, Eriko Koshimizu6, Satoko Miyatake6, Naomichi Matsumoto6, Yuko Arioka7, Norio Ozaki7, Yoichi Kato1, Shinji Saitoh1 (1. 名古屋市立大学大学院医学研究科、2. 自治医科大学医学部、3. 慶應義塾大学医学部、4. 東京医科歯科大学、5. 宮城県立こども病院、6. 横浜市立大学大学院医学研究科、7. 名古屋大学大学院医学系研究科)

×

Authentication

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

×

Please log in with your participant account.
» Participant Log In